318 filings
Page 3 of 16
DEFA14A
TCRR
Tcr2 Therapeutics Inc
22 May 23
Additional proxy soliciting materials
7:33am
425
TCRR
Tcr2 Therapeutics Inc
22 May 23
Business combination disclosure
7:33am
8-K
TCRR
Tcr2 Therapeutics Inc
22 May 23
Other Events
7:31am
4
TCRR
Tcr2 Therapeutics Inc
15 May 23
TCR2 THERAPEUTICS / KEVIN C TANG ownership change
5:12pm
10-Q
2023 Q1
TCRR
Tcr2 Therapeutics Inc
Quarterly report
11 May 23
7:15am
8-K
TCRR
Tcr2 Therapeutics Inc
11 May 23
TCR2 Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:00am
4
TCRR
Tcr2 Therapeutics Inc
10 May 23
TCR2 THERAPEUTICS / KEVIN C TANG ownership change
7:02pm
4
TCRR
Tcr2 Therapeutics Inc
5 May 23
TCR2 THERAPEUTICS / KEVIN C TANG ownership change
6:52pm
3
Tang Capital Management LLC
5 May 23
TCR2 THERAPEUTICS / KEVIN C TANG ownership change
6:49pm
SC 13G/A
TCRR
Tcr2 Therapeutics Inc
5 May 23
TCR2 THERAPEUTICS / TANG CAPITAL PARTNERS ownership change
4:37pm
DEFM14A
TCRR
Tcr2 Therapeutics Inc
20 Apr 23
Proxy related to merger
4:50pm
S-8
TCRR
Tcr2 Therapeutics Inc
23 Mar 23
Registration of securities for employees
7:51am
10-K
2022 FY
TCRR
Tcr2 Therapeutics Inc
Annual report
23 Mar 23
7:15am
8-K
TCRR
Tcr2 Therapeutics Inc
23 Mar 23
TCR2 Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
7:00am
8-K
TCRR
Tcr2 Therapeutics Inc
10 Mar 23
Regulation FD Disclosure
4:50pm
425
TCRR
Tcr2 Therapeutics Inc
9 Mar 23
Business combination disclosure
4:23pm
425
ADAP
Adaptimmune Therapeutics Plc
9 Mar 23
Business combination disclosure
4:17pm
425
TCRR
Tcr2 Therapeutics Inc
6 Mar 23
Business combination disclosure
4:31pm
425
TCRR
Tcr2 Therapeutics Inc
6 Mar 23
Business combination disclosure
4:29pm
425
TCRR
Tcr2 Therapeutics Inc
6 Mar 23
Business combination disclosure
4:27pm